´îªÎ¶ì¨­¡BÂׯݫü©wªù¶E

 

´îªÎ
¤U¸¡
Áv³¡

ÂׯݤH¤H³£´÷±æ¦³§¡¤Ãªº¨­µô¨Ã°l¨D¨­Å骺°·±d¡AªÎ­D¤£¥u¬O¬ü¤£¬üªº°ÝÃD¡A§ó¬O¨­Åé¦Ê¯f¤§·½¡A°I¦Ñ¤§º×­º¡A½Ã¥Í¸pªñ¤½§Gªº¤T°ª¡B¥NÁ¯g­Ô¸s±z¦W¦C¨ä¤¤¤F¶Ü?
¥»°|·s³¯¥NÁ¬ìÂå®v·|¬°±z¶q¨­©w°µ¡©¥þ¨­ªÎ­D«¬?¤¤¼s«¬?¦è¬v±ù«¬?¡ª½G¨­¦±½u¨t¦C¨Ã´£¨Ñ²Ó­MÀç¾i¡A¦n»´ÃP´î¡A¯·²À¶ì¡C¥[¥H¥Í¬¡¤W§@¨Ç¤p¤pªº­×¥¿¡A´N¤£·|½G¨ì¤£¸Ó½Gªº¦a¤è¡A¤]¤~¤£·|®e©ö´_­D¡C

º¡·N±zªº¯Ý³¡¦±½u¶Ü?§¹¬ü¤k¤Hªº¯µ±K¡AÅý±z¬üÄR¦Û«H¡A½à¤ß®®¥Ø¡B¬¡¤O¥R¨K¡B¤Ò©d·P±¡¡K¡K¡C
¥»°|±Ä¥Î§¹¥þ¯Â¤ÑµMªº°t¤è(¤£¬O¦X¦¨ªº)¡A°t¦X¥ý¶i»ö¾¹¡A¨Ã¦b±M¬ìÂå®v«ü¾É¤UÅý±z¤£¦A¦³¡©¤£ºÞ«ç»ò°µ¡AÁÙ¬O¤ñ§O¤H­D¡ªªº·P(¹Ä)´n¡C
Áo©úªº±z¡A»°§Ö§@©ú´¼ªº¿ï¾Ü¡A²{¦b´N¹w¬ù§a!

 

´î­«¡B¶ì¨­¡BÂ×¯Ý ªì¶E¡B½Æ¶E¬yµ{

ªì¶E

  1. ¹w¬ù (TEL:2756-3468)
  2. ±¾¸¹¡B¿Ô¸ß(Âå®v°Ý¶E)
  3. ´ú¶qÅé­«¡B¯Ý³ò¡BÁv³ò¡BÅé¯×ªÕ§t¶q¤ñ¡B¨­Åé ½è¶q«ü¼Æ
  4. Á¿¸ÑªÎ­D¤ÀÃþ¡B´î­«¤èªk¡B´î­«®Éµ{¡BÀøµ{¶O¥Î
  5. ³]©w¥Ø¼Ð
  6. ¹êÅç«ÇÀˬd(¦å²GÀˬd¡B§¿²GÀˬd¡A»ÝªÅ¸¡¤K¤p®É¥H¤W¡A¨ä¥LÂå®v«ü©wªº¯S®íÀˬd¡A¥t­q¤é´Á)

²Ä¤@¦¸½Æ¶E

  1. ±¾¸¹
  2. ¤ÀªRÀËÅçµ²ªG
  3. Âå®v¶}³B¤è¨Ã»¡©ú¨Ï¥Îµ{§Ç¤Îª`·N¨Æ¶µ
  4. ¶¼­¹¤Î¹B°Ê½Ã±Ð
  5. ·Ó¬Û
  6. ¹w¬ù¤U¦¸¦^¶E®É¶¡

 

Osolean

´î¯×¡B¶ì¨­·s°t¤è
Osolean¯»¥½¬O¤@ºØ±M§Qªº¨Å²M³J¥Õ²V¦Xª«°t¤è·í¥¦©M§C¼ö¶q¶¼­¹¤Î¾A·íªº¹B°Ê°t¦X¥i¥H¥[±j¯×ªÕªº®ø¥¢¦ý«O¦³½G¦Ù¦×¡C¤@¶µ¤HÅé¹êÅçµo²{

Osoleam¯»¥[¤W§C¼ö¶q¶¼­¹¡A12¬P´Á«á¤ñ³æ¿W­¹¥Î§C¼ö¶q¶¼­¹ªÌ¯×ªÕ´î¤Ö¬ù2­¿¡A³æ¿W±Ä¥Î§C¼ö¶q¶¼­¹ªÌ¡A´î¤ÖªºÅé­«¤@¥b¨Ó¦Û¯×ªÕ¡A¤@¥b¨Ó¦Û¦Ù¦×;¥[¤WOsolean¯»«á´î¤ÖªºÅé­«75%¨Ó¦Û¯×ªÕ¡C°£¤F³oºØ±j¤Oªº¯×ªÕ´î¤Ö¥\®Ä¤§¥~¡AOsolean¯»ÁÙ¬O¥þ¤ÑµMµL¨¾»G¾¯¡BµL²K¥[ª«¡A¦P®ÉÁÙ¨ÑÀ³:¨C¤@¥÷´£¨Ñ¥þ¤é³J¥Õ½è»Ý­n¶qªº20%¡A¥þ¤é¶t½è»Ý­n¶qªº22%;¦]¦¹Osolean¬O¥¿¦b´M¨D´î­«ªÌ¥i¾aªº¸É¥R«~¡C

¬ü°ê´£¨Ñªº¦³ÃöOsoLeanªº¥|­Ó­ì²z

1¡BContains protein rich in branch-chain amino acids (Leu, Ile, Val) ¡÷ protein synthesis

´I§t¤äÃìÓi°ò»Ä¡A¯àÀ°§U³J¥Õ½è¦X¦¨¡]§Y«O¯d¦Ù¦×¶q¡^®Ú¾Ú¹êÅç¡A±NOsoLean¥[¤J§C¥d¶¼­¹¤¤¡A°Ñ¥[ªÌ¦b12¶g´Á¶¡©Ò´î»´ªº¯×ªÕ¬O¥u±Ä¥Î§C¯×¶¼­¹ªÌªº¨â­¿¡C¦b­°§C¥d¸ô¨½ªº¶¼­¹²Õ¡A©Ò´î»´ªºÅé­«¤@¥b¬O¯×ªÕ¡A¥t¤@¥b¬O¦Ù¦×¡F¦ý¥[¤JOsoLean«á¡A©Ò´î»´ªºÅé­«´X¥G75%³£¬O¯×ªÕ¡C

¡i¾Ç²z­I´º¡j¤äÃìÓi°ò»Ä¡]branched-chain amino acids, BCAA¡^«ü¥ÕÓi»Ä¡]leucine, Leu¡^¡B²§¥ÕÓi»Ä¡]isoleucine, Ile¡^¤ÎõéÓi»Ä¡]valine, Val¡^¤T­Ó¤HÅ饲»ÝÓi°ò»Ä¡ABCAA¦û¤HÅé¦Ù¦×³J¥Õ½è¤¤Ói°ò»ÄÁ`¶q¬ù14-18 % (Riazi, Wykes, Ball, & Pencharz, 2003)¡C¸É¥RBCAA¥i¯à¥i¥H´î¤Ö¹B°Ê¯h³Ò²£¥Í¡A¦P®É´£°ª¦Ù¦×³J¥Õ½è¦X¦¨§@¥Î¡C??

2¡BContains ACE (angiotensin converting enzyme) inhibiting peptides ¡÷ adipose (fat cell) metabolism

§t¥i§í¨î¦åºÞ±i¤O¯ÀÂà´«?¡]ACE¡^ªºÐ`?¡A«P¶i¯×ªÕ¥NÁ¡]¿U¯×¡^

3¡BGlycomacropeptides stimulate release of cholecystokinin (CCK) ¡÷ satiation¨ä¤¤ªºÁÞ¥¨?¡]Glycomacropeptides¡^¯à¨ë¿EÁxÅn¦¬ÁY¯À¡]cholecystokinin¡ACCK¡^¡A¼W¥[¹¡­¹·P(­°§C­¹¶q)

¡i¾Ç²z­I´º¡jÁxÅn¦¬ÁY¯À¬O³y¦¨µu¼È¹¡¨¬·Pªº­«­n¦]¤l¡C¨Å²M³J¥Õ¤¤©Ò§tªºglycomacropeptides (GMPs)¥i¨ë¿E¤@ºØ±±¨î­¹¼¤ªº¸z­G²üº¸»Xcholecystokinin (CCK)ªº¤Àªc¡A¶i¤@¨B­°§C­¹¼¤¡C

4¡BCalcitrophic hormone regulation ¡÷ lipolysis

½Õ¸`ÁͶt¿E¯À¡]Calcitrophic hormone¡^¡A«P¶i¯×ªÕ¤À¸Ñ

Osolean Åý´îªÎÅܲ³æ&§Ö¼Ö

¤£¥Î¦Y¥NÀ\¡÷¤£¥Î¨¯­WÀ£§í¡A´îªÎ¥i¥H«Ü¥Í¬¡¤Æ¡®§Ö¼Ö
¤£¥Î§]½¦Ån¡A¿õª¬©Î³Ü¬Y¯S©w¶¼®Æ¡÷´îªÎ¥i¥H«Ü²³æ¡A»´ÃP
&¦Û¥Ñ
100%¤ÑµM¡AµL¤Æ¾Ç²K¥[¡÷´îªÎ¥i¥H«Ü¦w¥þ¨Ã­ÝÅU°·±d

§C¯×¡A§C¥d¥BµL¿}¡÷¤£¼vÅT¶¼­¹±±¨î¡A¦³°·±d°ÝÃDªÌ¤]¥i¦w¤ß¨Ï¥Î
°ªÀu½è³J¥Õ½è¡®°ª¶t¡÷­ÝÅUÀç¾i¸É¥R¡AÅý§A°·±d¨É½G

Osolean Åý´îªÎÅܲ³æ&§Ö¼Ö

Osolean Åý´îªÎÅܲ³æ&§Ö¼Ö

OsoLean¡A¸g¹êÅçÃÒ¹ê¨ä®Ä¯àªºÀu½è²£«~

Osolean Åý´îªÎÅܲ³æ&§Ö¼Ö

´î­«¥«³õ·§Æ[

¥þ²y¤H­Ì¦Y±o¦h¡A¹B°Ê«Ü¤Ö¡A³y¦¨¨C¦~¬üª÷890»õªº´î­«¨Æ·~

  1. ¬ü°ê¦û70%¡A¬ù622»õ¬üª÷¡A¨Ã¥B¨C¦~¦³6%¼Wªø²v
  2. ¤é¥»¬O²Ä¤G¤j¥«³õ
  3. ¿D¤j§Q¨È¨C¦~5»õ¬üª÷

²{¦bªÀ·|¦s¦b¸`­¹ÁͶաA§i¶D§Ú­Ì¤w¦³³\¦h¤H¦b¸`­¹¦Ó¥B¸`­¹¹Lªø¡A¥Ñ¤U¥iª¾:
2002¦~¡X¦³10%¨k¤H¸`­¹¡A²{¦b¤W¤É¨ì45%¡A¤k¤H«h¥Ñ23%¤W¤É¨ì61%¡C
2004¦~¡X¸`­¹2.5¦¸2007¦~¤W¤É¨ì4¦¸
¸`­¹¥­§¡´Á¶¡¬°10¬P´Á
¤k¤H¥­§¡ªø¹F6.4­Ó¤ë
¸`­¹ªÌ¤@¯ë±q20¦h·³´N¶}©lª½¨ì60¦h·³¡A¬ü°ê°ü¤k¤@¥Íªá¶O¦Ü¤Ö21¦~¦b¸`­¹¡C

½Ö¬O¥«³õ¥Ø¼Ð

  1. °w¹ï¥¼¨Ó®ø¶OªÌ¤Î¹ÎÅé

    ¥ø·~¥D­n³ÌÄ_¶Qªº¸ê²£¬O®É¶¡

    1. ´M§ä¨º¨Ç¤w¦³·N¹³­n¶R¡A·Q­n¶R©Î»{©w¤@¨Ç¹ï²£«~·|¦³¿³½ìªº¤H
    2. ¤£­n®ö¶O®É¶¡¦b¨º¨Ç±q¤£¦Ò¼{±zªº²£«~©Î¨S¿³½ìªº¤H¨­¤W

  2. Osolean¯»¥«³õ»·´º

¦¹²£«~°w¹ï35~65·³¦³·NÄ@±±¨îÅé­«ªº¨k¤k¡A¥Ø¼Ð«ü¦V±`±`¸`­¹«o¤S¤£±`°Êªº³o¨Ç®ø¶OªÌ;ÁöµM¤k¤H¸`­¹¬O¬°¤F¬üÆ[¡A¨k¤H¸`­¹¬°¤F°·±d¡A¦ý¤j®a²×¨s¥Ø¼Ð¬O¤@­Pªº¡A´N¬O­n¬Ý¨ìµ²ªG¡C

¤U­±Á|´X¦ìOsolean¨å«¬(²z·Q)ªº®ø¶OªÌ

  1. 43·³ªº®a®x¥D°ü¤£·QÄ~Äò²Â­«¦a­D¤U¥h¡A¦n·ÓÅU3­Ó¬¡ÅDªº¤p«Ä¡C
  2. 59·³§Y±N°h¥ðªº¨k©Ê¡A¦Û¤w¤£»{¬°¹L­«¡A¦ýÂå¥ÍÄU¥L­n´î¤Ö´X½SÅé­«¦nÅýÁx©T¾J¦b¥¿±`½d³ò¤º
  3. 36·³ªºÂ¾·~°ü¤k¡A¤j¾Ç¤@¦~¯ÅÅé­«¼W¥[«á´N¨S¤U­°¹L¡A²{¦b¤£ºÞ¥Î¤°»ò¤èªk¡A³£·Q«ì´_¨ì±q«e·í°Õ°Õ¶¤­û®ÉªºÅé­«¡C
  4. 40·³¥Rº¡¬¡¤Oªº¨k©Ê¡A©P¥½±`©M¹Ù¦ñ­Ì¥´Äx²y¡AÅéÅç¨ì·í¥L½G¤U¨Ó¤@¨Çªº®É­Ô¡A¥Lªº¸}¶]±o§ó§Ö¡C
  5. 52·³´_­D¸`­¹ªÌ¡A±q°ª¤¤´N«Ü¦b·NÅé­«¡A³Ìªñ¶C´M¨D¤U¤@¦¸²£«~¦n¤U­°¤W¦¸´îªÎ¤S´_­D¦^¨Óªº10½S­«¡C

«È¤á»Ý­n¨º¨Ç?

·í§AÁA¸Ñ«È¤áÁʶR´î­«²£«~ªº­«¾÷«á¡A¦³§U§A¦³®Äªº¦V¥L­Ì»¡©úOsolean¥i¥Hº¡¨¬¥L­Ìªº»Ý­n¤Î¬°¦ó­nÁʶR¥¦¡CÅU«È¹ï­¹¥Î´î­«¥Î«~¥D­n¦³3¤j»Ý¨D:

  1. ¦nµ²ªG:­n¯à¬Ý¨ì¦nªºµ²ªG¡A³o¬O²Ä¤@­n¨D¡AOsolean¤@©w¦³¦¨ªG¡A¦Ó¥B¤£¬O¤@¯ëªº¦¨ªG¡A¦Ó¬O¯×ªÕ´î¤Öªº¦¨ªG¡A¬O®Ú¾Ú³Ìªñ¤HÃþÁ{§É´ú¸ÕÃÒ©úOsolean
  2. ¯»¥[¤W§C¼ö¶q¶¼­¹©M¾A«×¹B°Ê¡A´î¤U¨ÓªºÅé­«75%¬O¯Âªº¯×ªÕ¡C
  3. ¤è«K©Ê:²£«~¨Ï¥Î­n²³æ¡B¤è«K¨Ã¥B¯à·»¤J¤é±`¥Í¬¡¤¤;¦­±ß¶º«e¦U2¤p°Í¥[¤ô©Î©M­¹ª«¤@°_¥Î¡C
  4. ¦n¨ý¹D: Osolean¯»¥i¥H©M³\¦hª««~²V¦X¡A¦pªG§A³ßÅwÁÙ¥i©M¶¼®Æ²V¦X¡AÄ´¦p©@°Ø¡B¤û¥¤¡BªG¥Ä¡B³\¦h¤H³ßÅw©M­»¯ó¡B¥©§J¤O¡B¨§¨Å¡B½\Ãþ¡BÀu¹T¨Å¡Bµæ´ö¡B¦×¥Ä¡C¦¹¥~ÁÙ¥iª½±µ¦pGlycoslim¥NÀ\¶¼®Æ²V¦X¡C

¤°»ò¨ÏOsolean¤ñ¸û¦n

¤@¡B¥D­n¯q³B

¦h¼Æ¼tµP¥uª`­«Åé­«ªº´î¤Ö¦h¤Ö¡A¦Ó¤£»¡¤j³¡¥÷´î¤U¨Óªº¬O¤ô¥÷¤Î½G¦Ù¦×¡AOsoleam¿W¯S¤§³B´N¦b´î¤Ö¯×ªÕ¡A¿Å¶qªº¤Ø«×¬O­^¦T¦Ó¤£¬O­^½S¡C

 Osoleanªº¯q³B¬O§O®a©Ò¨S¦³ªº:

  1. ¦X¨Ö¨Ï¥ÎOsolean¤Î¾A·í¹B°Ê¥i¥H 1)À°§U´î¤ÖÅé¯×ªÕ¦Ó«O¦í½G¦Ù¦×¡A?
  2. ¨Ã¥BÁÙ¥i§í¨î­¹¼¤¡A3)¥i¥H´î¤ÖÁv³ò´X­^¦T¡C
  3. ¨ÑÀ³µ´¨Îªº¶t½è
  4. ¨S¦³¤H¤u²K¥[ª«
  5. ¨S¦³¶ñ¥R®Æ¤Î¿}ºë

¤G¡B¥ý¶iªºÐ`?§Þ³N

±M§Qªº¯S®í§Þ³N¡AµÑ¨ú¨Å¼ß³J¥Õ¤ºªº¬Y¨Ç¸g¿@ÁY«á±o¨ìªº¦hÐ`?¡A¥i¥H²£¥Í³Ì¤jªº¯×ªÕ·»¸Ñ®ÄÀ³¡A¦P®É¥[¤W¨Å¼ß¤º§tÂ×´I¶t½èªºÄqª«½è¥H°t¦¨Osolean¯»¡C

¥D­n¦¨¥÷

¸ò§O¤Hªº¸`­¹­p¹º¤Î¥NÀ\¤£¤@¼Ë¡AOsolean©Ò¦³¦¨¥÷¬°¯Â¤ÑµM¡A¥i¿ë»{¡A¨S¦³¤£¥i§iª¾ªº¤Æ¾Çª«½è¡C

Àç¾i¼Ð¥Ü
¨C¥÷12.2¤½§J(2°Í)¡A¥»¥]¸Ë§t30¥÷
¨C¥÷§t¶q
¨C¤é»Ý­n¶q%
¼ö¶q
45
Áx©T¾J
¡Õ5mg
¡Õ1%
ºÒ¤ô¤Æ¦Xª«
¡Õ1g
¡Õ1%
³J¥Õ½è
10g
20%
¶t
225mg
22%
¶u
120mg
5%
 
Mannatech½Æ¤è
12.1g
³¡¥÷¤ô¸Ñ¨Å³J¥Õ
¨Å²MÄqª«½è½Æ¤è
 
¨ä¥L¦¨¥÷:¤j¨§§ZÁC¯×¡A§t¤j¨§¤û¨Å
 

§JªA²§Ä³

¥ô¦ó·s²£«~©Î·s§Þ³N¦b¾P°â®É³£·|¹J¨ì¤Ï¹ïªº·N¨£¡A¤U¦C¨Ç¦^À³¥i¨Ñ°Ñ¦Ò:

    1. ²§Ä³: Osolean¯»¤Ó¶Q¡A§Oªº¼tµP«K©y??
      ¦^À³:¨º¬O¯uªº¡AOsolean¯»¤£¬O´¶³qªº¨Å¼ß³J¥Õ¡A¦Ó¬O¤@ºØ¥ý¶iªºÐ`?³J¥Õ§Þ³N¡A¦P®ÉÁ{§É¬ã¨sÃҹ귻¸Ñ¾|ªÕ®É«O¦s½G¦×¡Aª½¾P°Ó¦Û°Ê­q³f¨C¤é¶Èªá¶O¬üª÷3¤¸¡A¤ñ¤@ªM®³ÅK©@°ØÁÙ«K©y¤S¥i´î¯×ªÕ¤S¥i¬ü»ª¡A¯u­È±oªº
    2. Å¥»¡¦³¤H¤ÏÀ³¨ý¹D¤£¦n??
      ¥¦¥i¥H¦p­¹ª«¤Î¶¼®Æ(©@°Ø¡B¤û¨Å¡BªG¥Äµ¥)²V¦X¦Y¡A¥¦©M¥ô¦óª««~ªº¿Ë©M«×«Ü¦n¡A¤j³¡¥÷¤H³ß·R©M­»¯ó©Î©@°Ø¨§¨Å¤@°_¡A¦P¼Ë¤]¦³¤H³ßÅw©M½\Ãþ¡BÀu¹T¨Å¡Bµæ´ö¡B¨F©ÔÂæ¤@°_¡A¦¹¥~§ó¥iª½±µ©MGlycoslim¥NÀ\º¯¦b¤@°_¦Y¡C
    3. ¦­¡B±ß¶º«e20¤ÀÄÁ¦Y¡A«Ü¤£¤è«K
      ?? ­n¦¨¥\´î­«¡A»Ý­n©Ó¿Õ¡A¤é±`¥Í¬¡¤¤¥[¤JOsolean³oºØ¤p§ïÅÜ·|¹ï§A²£¥Í¤jÅܤơA¤£­È±o¶Ü?¬°­nÀ°§U§AÂk¤J¥¿­y¡AÅý¥¦³QÂ\¦b¼p©Ð©Î¤u§@Âi¤W¡AÅܦ¨§A³Ì³ß·R¥Îªº;¦pªG¶º«e20¤ÀÄÁ¤£¤è«K¡A¥i¥H©M­¹ª«¦X¦b¤@°_¦Y¡C
    4. ¥ý«e¸`­¹¹L¡A¦ý¨S¦³¦nµ²ªG
      ?? Osolean©M¨ä¥L²£«~¤@¼Ë¬O¤@ºØ¥Í¬¡«¬ºAªº§ïÅÜ¡A¨S¦³¤@²ÉÅ]³N¤l¼u¥i¥H¤£»Ý§ïÅÜ¡A¥i¥H¤£»Ý§ïÅܶ¼­¹²ßºD¤Î¹B°Ê¦Ó¥i´î­«¡A¦pªG§A¨S¦³©Ó¿Õ¬OµLªk¹F¦¨²z·Q¥Ø¼Ðªº¡C¦pªGOsoleanÄ~Äò¨C¤Ñ¦Y2¦¸¹F8¬P´Á¥H¤W¡A¨Ã¥B´î¤Ö¼ö¶qªºÄá¨ú¤Î¼W¥[¹B°Ê¶q¬O¤£·|Åý§A¥¢±æªº¡C

 ±`¨£ªº°ÝÃD

  1. Osolean¯»¬O¤°»òªF¦è
    ¥¦¬O¤@ºØ¥þ¤ÑµM³J¥Õ½è²V¦Xª«;¦³Á{§ÉÃÒ¹ê°t¦X§C¼ö¶q¶¼­¹¤Î¾A«×¹B°Ê¥i¥H¹F¨ì®ø¯Ó¯×ªÕ¡A«O¦s½G¦×ªº¥Ø¼Ð¡C
  2. ¥¦ªº¦¨¥÷¬°¦ó?
    ¨Ï¥Î±M§Qªº³J¥ÕÐ`?¤ÀÂ÷¨Ã¿@ÁYªº¯S®í§Þ³N©Ò±o¨Óªº°t¤è¡A¥i¥HÀ°§U¨­Åé¿U¿N¯×ªÕ¦Ó¤£®ø¯Ó¦Ù¦×¡C
  3. ¤°»ò¬O³J¥Õ½èÐ`?§Þ³N?
    ³oºØ±M§Qªº§Þ³N¬O±q¨Å²M³J¥Õ¤º¤ÀÂ÷¥X¬Y¨Ç¯S®í³¡¥÷ªºÐ`?«á¥[¥H¿@ÁY©Ò±o¨ìªº¥i¥H¿U¿N¯×ªÕªº²z·Q¦¨¥÷¦A¥[¤W±o¦Û¨Å²M§tÂ×´I¶t½èªºÄqª«½è¡C
  4. ¨ý¹D¦p¦ó?
    Ãþ¦ü²æ¯×¨Å¯»ªº¨ý¹D
  5. ¦p¦óªA¥Î?
    2¤p°Í¥[¤J8¯s¥qªº²GÅé¡A¨C¤é2¦¸¡A¦­À\¤Î±ßÀ\«e20¤ÀÄÁªA¥Î®ÄªG³Ì¦n¡A¤]¥i¥H®Í¦b­¹ª«¤W©Î²V¦b­¹ª«ùØ¡C
  6. ¥i¥H©M¤°»òªF¦è²V¦X?
    ¥ô¦ó­¹ª«³£©M¥¦²V¦X§¹¥þ¡A¹³¬O¶¼®Æ(©@°Ø¡B¤û¨Å¡B¥NÀ\¡B³·ªw¡BªG¥Ä)¡B½\Ãþ¡BÀu¹T¨Å¡Bµæ´ö¡B¨F©Ô°t®Æ)¤ÎGlycoslim´îªÎ¥NÀ\¡C
  7. ¥i¥H©M¥¿À\¦X¥Î?
    ¥i¥Hªº¡AOsolean¯»¥i¥H©M¼Æ¤£ºÉªº­¹ª«²V¦X§¹¥þ¡A¥u¬O³Ì¦n¿í·Ó©Ò¥Iªº¨Ï¥Î«ü«n¡C
  8. Osolean¯»©M¤@¯ëªº¨Å²M³J¥Õ¦³¦ó¤£¦P?
    ¤j³¡¥÷ªº¨Å²M³J¥Õ¥u¬O¨Å²M¡AOsolean¨Ï¥Î±M§Qªº§Þ³N±q¨Å¼ß³J¥Õ¤º¤ÀÂ÷¥X¨Ã¿@ÁY¬Y¬q¯S®íªº³J¥ÕÐ`?¥i¥H½T«O¿U¿N¯×ªÕªº®ÄªG¡A³o¬O¨ä¥L¼tµP©Ò¨S¦³ªº;¦P®ÉOsolean¤]¤£§t¥ô¦ó¶ñ¥R¾¯¡B¿}ºë©Î¨¾»G¾¯¡C
  9. Osolean¯»©MGlycoslim¥NÀ\¶¼®Æ¦³¦ó¤£¦P?
    Glycoslim¥NÀ\¶¼®ÆÀ°¦£´î¤Ö¼ö¶q¡A¦ÓOsolean«h¬O¿U¿N¯×ªÕ¡A¬OGlycoslim20¤ÀÄÁ«e©M²GÅé¨Ï¥Î©Î¬O¨âªÌ²V¦X§¡¤Ã«á¨Ï¥Î¡C

 

 

Åé¯×ªÕ¡B¨­Åé½è¶q«ü¼Æ´ú¸Õ°O¿ý

 

 

¶q¤lÂå¾Ç¡U¦å²G¬¡ÅéÀË´ú¡U¦ÛµMÂå¾Ç¡UÀù¯g¾ãÅé¥Í©RÀøªk¡U¤º¤Àªc·s³¯¥NÁªù¶E¡U40¦~¦æÂå¤ß±o¡U

¡U§Ü°I¦Ñ¦^¬Kªù¶E¡UÁÞ½èÀç¾i¯À¡U¥Í¤Æ¹p®g¦å²GÀøªk ¡U³Ð·~¨}¾÷¡U¼x¨D¨ÑÀ³¼t°Ó¡U¦^­º­¶¡U